Proprio advances surgery through a proprietary platform that synthesizes artificial intelligence, computer vision, and augmented reality.
Our goal is to significantly improve patient outcomes and surgeon wellbeing through the collaboration of physician expertise and immersive, intelligent technology.
Our executive team has extensive experience in technology, neurosurgery, computer vision, and orthopedics. With dozens of FDA-approved products successfully brought to market, our leaders come from small, mid, and large technology and medical device companies, both private and public.
Gabriel Jones is the CEO of Proprio, which he co-founded in 2016 with Seattle Children's Hospital neurosurgeon Dr. Samuel Browd, University of Washington Professor Joshua Smith, and computer vision specialist James Youngquist. The team set out to create a system that makes surgeons more precise and exponentially increases surgical accuracy and efficiency.
Jones is a well-known and experienced technology leader with a passion for helping others and bringing innovation to life. Jones has more than a decade of leadership experience in emerging technology and intellectual property law, with specific expertise in AI and healthcare. He began his career in international trade in Japan and Washington, DC, and worked in large-scale mergers and acquisitions on Wall Street. Prior to founding Proprio, Jones helped clients like Bill Gates and the leadership of Microsoft evaluate and develop emerging technologies while working with the Bill & Melinda Gates Foundation on global initiatives in health and technology. Seeking to create a more direct, positive societal impact, his work led him to technology ventures. He has assisted several successful startups on their commercialization path, from biotech and med tech, to AI and prop tech. Gabe has held seats on several boards including the Washington Biotech and Biomedical Association and the Group Health Foundation through its acquisition by Kaiser.
Dr. Samuel R. Browd, M.D., Ph.D., FACS, FAANS, FAAP is Professor of Neurological Surgery at the University of Washington and Attending Neurosurgeon at Seattle Children’s Hospital. Dr. Browd is the Director of The Sports Institute at UW Medicine and Medical Director of the Seattle Children’s Sports Concussion Program.
Dr. Browd also serves as Seattle Children’s Director of Hydrocephalus, Surgical Director of the Tone Management Program and lead surgeon for the pediatric neurosurgical complex spine practice at Seattle Children’s Hospital. Dr. Browd is adjunct Professor of Bioengineering and affiliate faculty of the Foster School of Business. Dr. Browd has published over 125 peer reviewed medical publications and book chapters. Dr. Browd serves as an Unaffiliated Neurologic Consultant to the NFL and as an independent neurologic consultant to the Seattle Seahawks. Dr. Browd completed a combined M.D. and Ph.D at the University of Florida studying neuroplasticity and learning and his current research interests include robotics and computational healthcare. Dr. Browd has co-founded five venture backed biomedical start-up where he served as chief medical officer including Proprio, VICIS, Aqueduct Neuroscience, Navisonics, and AllCylinders. Dr. Browd also serves as a business and medical advisor to numerous early-stage biotech companies and serves as an advisor/technical filter for numerous venture capital firms. Dr. Browd serves as a UW Presidential Entrepreneurial Faculty Fellow and teaches at the UW Foster School of Business, he also lectures internationally on biomedical innovation and commercialization. Dr. Browd was recognized as the University of Washington School of Medicine Inventor of the Year in 2016 and co-developed two products that were listed as Time Magazine’s Invention of the Year in 2017 and 2019. Dr. Browd was honored to be the 2021 CNS Innovator of the Year.
Shannon brings 25 years of medical device experience in both early stage companies and large corporations. In her 27 year career she has been responsible for new product development, product manufacturing, and quality systems and has led teams along the full spectrum of the development lifecycle in a wide variety of clinical applications.
Prior to joining Proprio she served as VP, Device Development for L'Oreal, VP of Engineering and Operations for an early stage start-up, Aortica Corporation and over a decade at Pathway Medical last acting as Director of Engineering. In her role at Pathway Medical she was a key part of the leadership team successfully transitioning the technology to Bayer Healthcare. Shannon holds a BS in Mechanical Engineering from Louisiana State University.
With over 25 years of experience in the regulated software industry, Neeraj most recently was the VP of Software Engineering at Vicarious Surgical, a Boston-based surgical robotics start-up where he was instrumental in developing the software architecture.
Prior to Vicarious Surgical, Neeraj led a global informatics and software engineering team at BD’s Integrated Diagnostic Solutions with multiple successful releases of their global informatics platform for micro and molecular biology laboratory automation. A computational physicist by training, Neeraj is passionate about medical technology software and strongly believes in the application of advanced digital technologies in the OR to support the enhancement of surgeon performance and improved patient outcomes.
Ray brings more than 25 years of results-oriented strategic business leadership to the Proprio team. Throughout his career, Ray has led finance and accounting, budgeting and planning, human resources, facilities, customer service, and logistics.
Focused on progressive responsibility with broad experience, Ray’s background includes IPO, venture capital and debt financings, strategic investments, acquisitions, divestitures and asset sales, and investor relations and capital markets strategy. He also managed financial processes and controls development, budget, modeling, and strategic planning processes, human resources and cultural leadership, and risk management and corporate legal. Ray was the CFO at Northstar Neuroscience, an early-stage medical device company that raised several rounds of venture and strategic financing and went through a successful IPO. Most recently, he served as the Chief Financial Officer at Atlas Coffee Importers, and has also served in leadership roles at LeMond Fitness, Altrec.com, and Ernst & Young. Ray holds a B.A. in Business Administration, Accounting Concentration from the University of Washington.
Having previous experience in joint replacement medical devices, Tommy Carls most recently served as the Vice President of Research and Development at market-leading Medtronic Spine & Biologics where he was responsible for all engineering activities for the approximately $2.8B annual revenue medical technology group.
His career at Medtronic included leadership positions in marketing for spinal navigation technologies as well as the thoracolumbar implants. He has launched 40+ products from both the marketing and engineering functions in the medical device industry and was a corporate leader/co-sponsor for Medtronic’s Women in Science and Engineering (WISE). Carls received his Bachelor of Science in mechanical engineering from Tulane University and his MBA from the University of Memphis.Carls was formerly an independent medical device consultant, and served on Proprio’s Clinical Advisory Board before joining Proprio full-time as their Vice President of Product Management & Marketing in January 2022. He holds more than 80 patents, has led global teams of more than 150 engineers, and is held in high regard by the top clinical and industry leaders in the global spine market.
Jim Youngquist has developed solutions in computer vision and robotics throughout his career. His work focuses on digitizing biological systems for machine understanding and enhancing human capabilities, particularly in high-tech solutions for safety-critical endeavors helping prevent loss of life.
As a PhD student at the University of Washington Sensor Systems Lab, Jim collaborated with computer scientists and electrical engineers on projects ranging from augmented reality to robotics to low power embedded computation. That work led him to build the early technology pipeline for Proprio. Since 2016 he has led the development of Proprio’s light field capture and render system from inception to deployable systems. He previously was the lead software architect at robotics startup Wibotic (co-founded by Dr. Josh Smith), for which he won the UW CSE Outstanding Engineer Award in 2015. Jim also has experience with advanced systems at Google and Intel. Jim was an Arabic translator in the Air Force in direct support of U.S. troops, and also speaks German.
Jones is a well-known and experienced technology leader with a passion for helping others and bringing innovation to life. Jones has more than a decade of leadership experience in emerging technology and intellectual property law, with specific expertise in AI and healthcare. He began his career in international trade in Japan and Washington, DC, and worked in large-scale mergers and acquisitions on Wall Street. Prior to founding Proprio, Jones helped clients like Bill Gates and the leadership of Microsoft evaluate and develop emerging technologies while working with the Bill & Melinda Gates Foundation on global initiatives in health and technology. Seeking to create a more direct, positive societal impact, his work led him to technology ventures. He has assisted several successful startups on their commercialization path, from biotech and med tech, to AI and prop tech. Gabe has held seats on several boards including the Washington Biotech and Biomedical Association and the Group Health Foundation through its acquisition by Kaiser.
Dr. Browd also serves as Seattle Children’s Director of Hydrocephalus, Surgical Director of the Tone Management Program and lead surgeon for the pediatric neurosurgical complex spine practice at Seattle Children’s Hospital. Dr. Browd is adjunct Professor of Bioengineering and affiliate faculty of the Foster School of Business. Dr. Browd has published over 125 peer reviewed medical publications and book chapters. Dr. Browd serves as an Unaffiliated Neurologic Consultant to the NFL and as an independent neurologic consultant to the Seattle Seahawks. Dr. Browd completed a combined M.D. and Ph.D at the University of Florida studying neuroplasticity and learning and his current research interests include robotics and computational healthcare. Dr. Browd has co-founded five venture backed biomedical start-up where he served as chief medical officer including Proprio, VICIS, Aqueduct Neuroscience, Navisonics, and AllCylinders. Dr. Browd also serves as a business and medical advisor to numerous early-stage biotech companies and serves as an advisor/technical filter for numerous venture capital firms. Dr. Browd serves as a UW Presidential Entrepreneurial Faculty Fellow and teaches at the UW Foster School of Business, he also lectures internationally on biomedical innovation and commercialization. Dr. Browd was recognized as the University of Washington School of Medicine Inventor of the Year in 2016 and co-developed two products that were listed as Time Magazine’s Invention of the Year in 2017 and 2019. Dr. Browd was honored to be the 2021 CNS Innovator of the Year.
Prior to joining Proprio she served as VP, Device Development for L'Oreal, VP of Engineering and Operations for an early stage start-up, Aortica Corporation and over a decade at Pathway Medical last acting as Director of Engineering. In her role at Pathway Medical she was a key part of the leadership team successfully transitioning the technology to Bayer Healthcare. Shannon holds a BS in Mechanical Engineering from Louisiana State University.
Prior to Vicarious Surgical, Neeraj led a global informatics and software engineering team at BD’s Integrated Diagnostic Solutions with multiple successful releases of their global informatics platform for micro and molecular biology laboratory automation. A computational physicist by training, Neeraj is passionate about medical technology software and strongly believes in the application of advanced digital technologies in the OR to support the enhancement of surgeon performance and improved patient outcomes.
Focused on progressive responsibility with broad experience, Ray’s background includes IPO, venture capital and debt financings, strategic investments, acquisitions, divestitures and asset sales, and investor relations and capital markets strategy. He also managed financial processes and controls development, budget, modeling, and strategic planning processes, human resources and cultural leadership, and risk management and corporate legal. Ray was the CFO at Northstar Neuroscience, an early-stage medical device company that raised several rounds of venture and strategic financing and went through a successful IPO. Most recently, he served as the Chief Financial Officer at Atlas Coffee Importers, and has also served in leadership roles at LeMond Fitness, Altrec.com, and Ernst & Young. Ray holds a B.A. in Business Administration, Accounting Concentration from the University of Washington.
His career at Medtronic included leadership positions in marketing for spinal navigation technologies as well as the thoracolumbar implants. He has launched 40+ products from both the marketing and engineering functions in the medical device industry and was a corporate leader/co-sponsor for Medtronic’s Women in Science and Engineering (WISE). Carls received his Bachelor of Science in mechanical engineering from Tulane University and his MBA from the University of Memphis.Carls was formerly an independent medical device consultant, and served on Proprio’s Clinical Advisory Board before joining Proprio full-time as their Vice President of Product Management & Marketing in January 2022. He holds more than 80 patents, has led global teams of more than 150 engineers, and is held in high regard by the top clinical and industry leaders in the global spine market.
As a PhD student at the University of Washington Sensor Systems Lab, Jim collaborated with computer scientists and electrical engineers on projects ranging from augmented reality to robotics to low power embedded computation. That work led him to build the early technology pipeline for Proprio. Since 2016 he has led the development of Proprio’s light field capture and render system from inception to deployable systems. He previously was the lead software architect at robotics startup Wibotic (co-founded by Dr. Josh Smith), for which he won the UW CSE Outstanding Engineer Award in 2015. Jim also has experience with advanced systems at Google and Intel. Jim was an Arabic translator in the Air Force in direct support of U.S. troops, and also speaks German.
Jones is a well-known and experienced technology leader with a passion for helping others and bringing innovation to life. Jones has more than a decade of leadership experience in emerging technology and intellectual property law, with specific expertise in AI and healthcare. He began his career in international trade in Japan and Washington, DC, and worked in large-scale mergers and acquisitions on Wall Street. Prior to founding Proprio, Jones helped clients like Bill Gates and the leadership of Microsoft evaluate and develop emerging technologies while working with the Bill & Melinda Gates Foundation on global initiatives in health and technology. Seeking to create a more direct, positive societal impact, his work led him to technology ventures. He has assisted several successful startups on their commercialization path, from biotech and med tech, to AI and prop tech. Gabe has held seats on several boards including the Washington Biotech and Biomedical Association and the Group Health Foundation through its acquisition by Kaiser.
Dr. Browd also serves as Seattle Children’s Director of Hydrocephalus, Surgical Director of the Tone Management Program and lead surgeon for the pediatric neurosurgical complex spine practice at Seattle Children’s Hospital. Dr. Browd is adjunct Professor of Bioengineering and affiliate faculty of the Foster School of Business. Dr. Browd has published over 125 peer reviewed medical publications and book chapters. Dr. Browd serves as an Unaffiliated Neurologic Consultant to the NFL and as an independent neurologic consultant to the Seattle Seahawks. Dr. Browd completed a combined M.D. and Ph.D at the University of Florida studying neuroplasticity and learning and his current research interests include robotics and computational healthcare. Dr. Browd has co-founded five venture backed biomedical start-up where he served as chief medical officer including Proprio, VICIS, Aqueduct Neuroscience, Navisonics, and AllCylinders. Dr. Browd also serves as a business and medical advisor to numerous early-stage biotech companies and serves as an advisor/technical filter for numerous venture capital firms. Dr. Browd serves as a UW Presidential Entrepreneurial Faculty Fellow and teaches at the UW Foster School of Business, he also lectures internationally on biomedical innovation and commercialization. Dr. Browd was recognized as the University of Washington School of Medicine Inventor of the Year in 2016 and co-developed two products that were listed as Time Magazine’s Invention of the Year in 2017 and 2019. Dr. Browd was honored to be the 2021 CNS Innovator of the Year.
Emotient was acquired by Apple in 2016. Ken has also been CEO of two Silicon Valley public software companies, including Openwave (since re-named Unwired Planet) where he directed this NASDAQ listed mobile middleware technology company through a major strategy transition. At iPass, Ken was Chairman and CEO and led a successful IPO in 2003. He has also served as Senior Vice President for MediaOne, leading a significant portion of the cable operator’s US operations. He previously served as Chief Operating Officer, Wireless, for MediaOne in London. Ken sits on the boards of Costco, Motorola, and the University of Washington Foundation. Ken sits on the boards of Costco, Motorola, VMware and Seattle Children's Hospital. He is an advisory board member of the UW Foster School of Business.
Alan serves on the Board of Directors of numerous DCVC portfolio companies including Evolv Technology, Kentik, and Caption Health. Prior to DCVC, Alan was the Chief Commercial Officer and served on the Board of Directors at Illumio, one of DCVC’s portfolio companies. Before Illumio, Alan was VP of Marketing at Nicira, which was acquired by VMWare for $1.3 billion. Prior to Nicira, Alan served as VP and head of marketing for Cisco’s $25 billion enterprise business, managing over 400 people and 25 product lines. Alan came to Cisco via the $460M acquisition of Airespace, where he was an early employee and served as VP of Marketing and Product Management. Alan received an MBA from NYU Stern School of Business, an MA in International Affairs from American University and a BA from SUNY Buffalo.
A graduate of Cambridge University in electrical engineering, he holds a PhD in plasma physics and a master’s degree in finance from MIT. Teymour has a deep interest in disruptive technologies, digital health, synthetic biology, and Internet of Things, and has lectured on entrepreneurship at UCLA.
Dr. Levy's notable previous leadership experiences include serving as the founding Chief Executive Officer at Incline Therapeutics, acquired by The Medicines Company for $390 million, Chief Executive Officer and President at Northstar Neuroscience, which raised $112 million in their IPO, Chief Executive Officer and President at Heartstream, acquired by Hewlett-Packard for $140 million, and President at Heart Technology, acquired by Boston Scientific for $500 million. In addition, he held several leadership positions at Ethicon, a division of Johnson & Johnson, including Vice President of Research and New Business Development and Director. Dr. Levy serves as a board member at several public and private companies including Intuitive Surgical, Tasso, and Abryx. He received his PhD in organic chemistry from Purdue University, a bachelor’s degree in chemistry from City University of New York, and holds an honorary doctor of science from Purdue University.
Dr. Berven serves on the Board of Directors of the Scoliosis Research Society, the Evaluation Committee of the American Academy of Orthopedic Surgery, the executive committee of the US Bone and Joint Decade Initiative, and he has been Chairman of the Value Council of the North American Spine Society.
He is the Committee Chair for the Canadian Spine Outcomes and Research Network (CSORN) and is the former Chairman of the AO Knowledge Forum, Tumour and is the Chair elect of the AO Spine International Research Commission. In 2013 and 2016, Dr. Fisher was honored as one of the top 28 spine surgeons in North America and in 2019 was awarded the North American Spine Society’s Leon Wiltse Award. He previously served as the President of the Canadian Spine Society.
He then completed both neurosurgical and orthopaedics residencies at the University of Virginia, followed by a spine fellowship in pediatric and adult reconstructive spine surgery in 1995. Following completion of his surgical training, he was appointed to the senior staff in the departments of neurological surgery and orthopaedic surgery at Detroit’s Henry Ford Hospital where he was actively involved in treating members of Detroit’s college and professional athletic teams. In 1999, Shaffrey was appointed associate professor of neurological surgery and adjunct associate professor of orthopaedic surgery and sports medicine at the University of Washington in Seattle. In 2003, he returned to the University of Virginia as professor of neurological surgery and director of the neurosurgery spine division. In 2008, he was named Harrison Distinguished Teaching Professor of Neurological and Orthopaedic Surgery. In July of 2018, Dr. Shaffrey was named the chief of the Duke Spine Division for the departments of Orthopaedic Surgery and Neurological Surgery and is a tenured professor of Orthopaedic and Neurological Surgery. Dr. Shaffrey is Board-certified in the fields of neurological surgery and orthopaedic surgery and has more than 450 peer-reviewed publications and more than 1000 national and international presentations. He has served or is serving as the Deputy Editor of the journals Spine and Spine Deformity and has served as the Chair of the Editorial Board for JNS: Spine as well as being an editor for several textbooks on spinal surgery. He has been the Chair of the ABNS and is currently a member of the Neurosurgery Residency Review Committee. He is the past president of the American Association of Neurological Surgeons and the president elect for the Scoliosis Research Society.
Dr. Gokaslan was then recruited to the Department of Neurosurgery at Johns Hopkins as the Donlin M. Long Professor, Professor of Neurosurgery, Orthopaedic Surgery and Oncology and Vice-Chair and Director of the Spinal Surgery Program where he served on the faculty for 13 years and established one of the most respected academic spine programs before joining The Warren Alpert School of Brown University. He is a recipient of numerous prestigious awards, including the Leon Wiltse Award to recognize his excellence in leadership and clinical research in spine care by the North American Spine Society (NASS), and is also an active member of many professional societies including the American Academy of Neurosurgeons, the World Academy of Neurosurgeons, and the Society of Neurological Surgeons. He also served as Chairman of the AANS/CNS Joint Sectionon Disorders of the Spine and Peripheral Nerves.
Dr. Kanade works in multiple areas of robotics: computer vision, multi-media, manipulators, autonomous mobile robots, medical robotics and sensors. He has written more than 400 technical papers and reports in these areas, and holds more than 20 patents. He has been the principal investigator of more than a dozen major vision and robotics projects at Carnegie Mellon. Dr. Kanade’s other professional honors include: election to the National Academy of Engineering, the American Academy of Arts and Sciences, a Fellow of IEEE, a Fellow of ACM, and a Fellow of American Association of Artificial Intelligence; several awards including Kyoto Prize, the Benjamin Franklin Institute Medal and Bower Prize, C&C Award, Okawa Award, ACM/AAAI Allen Newell Award, Joseph Engelberger Award, IEEE Robotics and Automation Society Pioneer Award, and ICCV Azriel Rosenfeld Lifetime Accomplishment Award.
Dr. Wetzstein is the recipient of a National Science Foundation CAREER Award, an Alfred P. Sloan Fellowship, an ACM SIGGRAPH Significant New Researcher Award and a Presidential Early Career Award for Scientists and Engineers (PECASE).
Josh received his PhD with Neil Gershenfeld at the MIT Media Lab, where he did groundbreaking work in electrical field sensing that has yielded real-life applications in areas such as automotive passenger sensing in smart airbag systems. His work on electric field sensing has also influenced the multi-touch capacitive sensing products that have been incorporated in smart phones since the iPhone. Josh began his career as Chief Scientist at Escher Group, a startup born at MIT. Prior to joining the UW faculty, he worked as a Principal Engineer at Intel. At the University of Washington, Josh’s Sensor Systems Lab has spun out two other venture-backed companies: Jeeva Wireless and Wibotic. With Proprio, Josh is exploring a new angle on research themes that he has long engaged with, including novel camera systems, human pose tracking, image processing, and interpretation of complex sensor data—all of which apply to the challenges of estimating anatomical geometry from a light field array of images, for the greatest accuracy and real-time 3D visualization during surgery.
During his 15 years at Microsoft, Desney has shipped his work in various versions of Windows and Office, the Microsoft Handwriting Recognition Engine and Tablet Input Panel, Xbox Kinect, and the Microsoft Band. Desney also holds an affiliate faculty appointment in Computer Science and Engineering at the University of Washington. Desney earned a bachelor’s degree in computer engineering from the University of Notre Dame, spent a couple of years in the Singapore Armed Forces, and subsequently earned his PhD in computer science from Carnegie Mellon University. Desney was honored as one of MIT Technology Review’s “2007 Young Innovators Under 35” for his work on brain-computer interfaces and a 2012 Kavli Fellow by the U.S. National Academy of Sciences. He was named one of SciFi Channel’s “Young Visionaries” at TED 2009, as well as Forbes’ “Revolutionaries: Radical Thinkers and their World-Changing Ideas,” for work on Whole Body Computing. Desney has over 100 peer-reviewed publications, more than 80 granted patents, with a similar number pending, and has personally invested in more than 80 early stage startup companies.
She then went on to complete a fellowship in complex spinal disorders at the University of Utah, under the direction of Dr. Ronald Apfelbaum. She joined the Spine Division in the Department of Neurosurgery at the University of Utah in 2009. Within the department, she serves as the Director of the CAST approved Neurosurgical Spine Fellowship and as the Vice Chair for Diversity and Inclusion. Dr. Bisson is a fellow of the American Board of Neurological Surgeons, and a member of the American Association of Neurological Surgeons, Spine Section. She has published over 100 peer-reviewed articles and serves as principal investigator on several national and international multicenter trials. She continues to work collaboratively on research with faculty in Neuroradiology and Exercise and Sports Medicine at the University of Utah as well as Neurosurgery Spine faculty at the Medical College of Wisconsin. Additionally, she serves in many leadership roles in national neurosurgical organizations, including being a member of the Editorial Board for the Journal of Neurosurgery and serving as the Scientific Program Chair for the AANS/CNS Joint Section on Spine and Peripheral Nerves. Most recently, Dr. Bisson was also elected to a 2 year term as the President of the University of Utah Medical Board. Dr. Bisson specializes in complex spine surgery with a focus on cervical disease (neck pain), utilizing both novel artificial disc and fusion technology. She also treats patients with spinal cord injury, spine trauma, and degenerative spinal conditions (neck and back pain). Dr. Bisson’s professional interests include occipitocervical disease, cervical degenerative disorders, advanced spinal fusion techniques, and image-guided surgery.
He is the Medical Director at Norton Leatherman Spine Center, Professor of Orthopaedic Surgery at the University of Louisville, Past-President of the Scoliosis Research Society, and Co-Chair of the American Spine Registry (ASR).
As an investigator on multiple institutional, industry and NIH-funded grants, he has helped pioneer a translational approach to incorporating patient-specific imaging and physiological data into computer simulations of aneurysm hemodynamics, and has developed novel techniques for intraprocedural neuronavigation using preoperative imaging such as CT and MRI. As the Director of Clinical Operations for Proprio, he supports the scientific pathway between engineering research and direct patient care, overseeing the studies that will set the stage for clinical trials and commercialization.
Dr. Saigal earned his M.D. at Tufts University, Medford, Massachusetts and his Ph.D. and M.Sc. at Harvard-MIT. He is the recipient of numerous awards for research, teaching and leadership, including the Boldrey Young Investigator Award, UCSF Neurosurgery Research and Rosegay awards, NSF Graduate Research Fellowship, Whitaker Graduate Research Fellowship and the Washington Spinal Cord Injury Consortium grant.
Josh received his PhD with Neil Gershenfeld at the MIT Media Lab, where he did groundbreaking work in electrical field sensing that has yielded real-life applications in areas such as automotive passenger sensing in smart airbag systems. His work on electric field sensing has also influenced the multi-touch capacitive sensing products that have been incorporated in smart phones since the iPhone. Josh began his career as Chief Scientist at Escher Group, a startup born at MIT. Prior to joining the UW faculty, he worked as a Principal Engineer at Intel. At the University of Washington, Josh’s Sensor Systems Lab has spun out two other venture-backed companies: Jeeva Wireless and Wibotic. With Proprio, Josh is exploring a new angle on research themes that he has long engaged with, including novel camera systems, human pose tracking, image processing, and interpretation of complex sensor data—all of which apply to the challenges of estimating anatomical geometry from a light field array of images, for the greatest accuracy and real-time 3D visualization during surgery.
She is also the Founding and Executive Director of the Biomedical Zone, Canada’s first and only, hospital-embedded, physician-led med tech incubator. Since founding the Biomedical Zone in 2015, she has developed over 70 med tech and digital health startup companies with several exits, facilitating over $60 million in private investment. Her startups have engaged hundreds of clinicians and have impacted over 67,000 patients. An Adjunct Professor of Surgery at the University of Toronto and Associate Scientist at the Li Ka Shing Knowledge Institute in Toronto, she is a published scientific author, medical educator, and frequent public speaker. Dr. Maxwell has been recognized as Canada’s Top 100 Most Powerful Women by the Women’s Executive Network, Top 30 Women Making a Difference in Tech, Top 100 Accomplished Black Women in Canada. She is the recipient of the Hayes Prize in Operations Management from Oxford and the Grayson Administrative Leadership Award from Toronto Metropolitan University. Dr. Maxwell earned a bachelor’s degree in Biology with honors from Harvard University, an M.D. from Yale University, and an M.B.A. from the University of Oxford. She completed six years of residency and fellowship training in Otolaryngology-Head Neck Surgery at the University of Toronto and is double-board certified in Otolaryngology and Facial Plastic Reconstructive Surgery. She is passionate about good corporate governance. She is a certified Independent Corporate Director (ICD.D) and is pursuing the Diligent Climate Leadership Certificate. Her boards/committees include: United Therapeutics, Audit; ImmunityBio, Compensation Chair, Audit, Related Party Transactions; Public Health Agency of Canada, Departmental Audit Committee (Federal appointment).
The Proprio Team is growing and needs creative thinkers and innovative problem solvers ready to make an impact!
By subscribing you agree to our Privacy Policy